Is the cholesteryl ester transfer protein proatherogenic or antiatherogenic in humans?

被引：13
作者：
Cuchel, Marina
Rader, Daniel J.
机构：
[1] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 50卷 / 20期
关键词：
D O I：
10.1016/j.jacc.2007.07.059
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1956 / 1958
页数：3
相关论文
共 22 条
[1]   Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women - The prospective EPIC (European Prospective Investigation into Cancer and Nutrition) - Norfolk population study [J].
Boekholdt, SM ;
Kuivenhoven, JA ;
Wareham, NJ ;
Peters, RJG ;
Jukema, JW ;
Luben, R ;
Bingham, SA ;
Day, NE ;
Kastelein, JJP ;
Khaw, KT .
CIRCULATION, 2004, 110 (11) :1418-1423
[2]   High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides [J].
Borggreve, Susanna E. ;
Hillege, Hans L. ;
Dallinga-Thie, Geesje M. ;
de Jong, Paul E. ;
Wolffenbuttel, Bruce H. R. ;
Grobbee, Diederik E. ;
van Tol, Arie ;
Dullaart, Robin P. F. .
EUROPEAN HEART JOURNAL, 2007, 28 (08) :1012-1018
[3]   An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: A population-based study [J].
Borggreve, Susanna E. ;
Hillege, Hans L. ;
Wolffenbuttel, Bruce H. R. ;
de Jong, Paul E. ;
Zuurman, Mike W. ;
van der Steege, Gerrit ;
van Tol, Arie ;
Dullaart, Robin P. F. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09) :3382-3388
[4]   The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia [J].
de Grooth, GJ ;
Smilde, TJ ;
van Wissen, S ;
Klerkx, AHEM ;
Zwinderman, AH ;
Fruchart, JC ;
Kastelein, JJP ;
Stalenhoef, AFH ;
Kuivenhoven, JA .
ATHEROSCLEROSIS, 2004, 173 (02) :261-267
[5]   Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: Role of CETP and triglycerides [J].
de Vries, R ;
Perton, FG ;
Dallinga-Thie, GM ;
van Roon, AM ;
Wolffenbuttel, BHR ;
van Tol, A ;
Dullaart, RPF .
DIABETES, 2005, 54 (12) :3554-3559
[6]   Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography [J].
Goto, A ;
Sasai, K ;
Suzuki, S ;
Fukutomi, T ;
Ito, S ;
Matsushita, T ;
Okamoto, M ;
Suzuki, T ;
Itoh, M ;
Okumura-Noji, K ;
Yokoyama, S .
ATHEROSCLEROSIS, 2001, 159 (01) :153-163
[7]   Higher level of plasma cholesteryl ester transfer activity from high-density lipoprotein to apo B-containing lipoproteins in subjects with angiographically detectable coronary artery disease [J].
Hibino, T ;
Sakuma, N ;
Sato, T .
CLINICAL CARDIOLOGY, 1996, 19 (06) :483-486
[8]   Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan - Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity [J].
Hirano, K ;
Yamashita, S ;
Nakajima, N ;
Arai, T ;
Maruyama, T ;
Yoshida, Y ;
Ishigami, M ;
Sakai, N ;
KamedaTakemura, K ;
Matsuzawa, Y .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (06) :1053-1059
[9]   Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia [J].
Kastelein, John J. P. ;
van Leuven, Sander I. ;
Burgess, Leslie ;
Evans, Greg W. ;
Kuivenhoven, Jan A. ;
Barter, Philip J. ;
Revkin, James H. ;
Grobbee, Diederick E. ;
Riley, Ward A. ;
Shear, Charles L. ;
Duggan, William T. ;
Bots, Michiel L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (16) :1620-1630
[10]   Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS) [J].
Klerkx, AHEM ;
de Grooth, GJ ;
Zwinderman, AH ;
Jukema, JW ;
Kuivenhoven, JA ;
Kastelein, JJP .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 (01) :21-28
123